205 related articles for article (PubMed ID: 32640498)
61. Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure.
Linn SM; Novitzky-Basso I; Patriquin C; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Barth D; Kim DDH
Leuk Res; 2023 Nov; 134():107387. PubMed ID: 37734221
[TBL] [Abstract][Full Text] [Related]
62. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
63. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).
Jagasia MH; Savani BN; Stricklin G; Engelhardt B; Kassim A; Dixon S; Chen H; Chinratanalab W; Goodman S; Greer JP; Schuening F
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1288-95. PubMed ID: 19747637
[TBL] [Abstract][Full Text] [Related]
64. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
65. Early initiation of extracorporeal photochemotherapy increases response for chronic graft versus host disease following steroid failure.
Gunduz M; Atilla E; Atilla PA; Topcuoglu P; Ilhan O
Transfus Clin Biol; 2019 Feb; 26(1):32-37. PubMed ID: 29655590
[TBL] [Abstract][Full Text] [Related]
66. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.
Tsirigotis P; Kaloyannidis P; Papalexandri A; Baltadakis I; Karakasis D; Batsis I; Sakellari I; Kitra V; Goussetis E; Papageorgiou S; Spyridonidis A; Graphakos S; Harhalakis N; Dervenoulas I; Anagnostopoulos A
Transfus Apher Sci; 2012 Apr; 46(2):173-80. PubMed ID: 22036202
[TBL] [Abstract][Full Text] [Related]
67. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
68. Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden.
Schain F; Boissin C; Laczik T; Fedeli S; Remberger M; Blennow O; Dykes J; Eich T; Jones C; Mattsson J; Berlin G
Transfus Apher Sci; 2023 Jun; 62(3):103705. PubMed ID: 36967367
[TBL] [Abstract][Full Text] [Related]
69. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies.
Abu-Dalle I; Reljic T; Nishihori T; Antar A; Bazarbachi A; Djulbegovic B; Kumar A; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1677-86. PubMed ID: 24867779
[TBL] [Abstract][Full Text] [Related]
70. Photopheresis long after the initiation of chronic graft versus host in a child.
Uygun V; Daloglu H; Karasu G; Yeşilipek A
Transfus Apher Sci; 2014 Oct; 51(2):172-4. PubMed ID: 25217990
[TBL] [Abstract][Full Text] [Related]
71. Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Worel N; Lehner E; Führer H; Kalhs P; Rabitsch W; Mitterbauer M; Hopfinger G; Greinix HT
Transfusion; 2018 Apr; 58(4):1045-1053. PubMed ID: 29446444
[TBL] [Abstract][Full Text] [Related]
72. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
73. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009759. PubMed ID: 26666580
[TBL] [Abstract][Full Text] [Related]
74. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
[TBL] [Abstract][Full Text] [Related]
75. Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: a case report.
Gigli F; Gardellini A; Babic A; Liptrott SJ; Castagna L; Martinelli G; Laszlo D
Transfus Apher Sci; 2013 Oct; 49(2):205-7. PubMed ID: 23491865
[TBL] [Abstract][Full Text] [Related]
76. The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
Bladon J; Taylor PC
Transpl Int; 2006 Apr; 19(4):319-24. PubMed ID: 16573548
[TBL] [Abstract][Full Text] [Related]
77. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
Greinix HT; Worel N; Just U; Knobler R
Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
[TBL] [Abstract][Full Text] [Related]
78. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
Spisek R; Gasova Z; Bartunkova J
Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
[TBL] [Abstract][Full Text] [Related]
79. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960
[TBL] [Abstract][Full Text] [Related]
80. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
